Triferic Avnu patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7816404 ROCKWELL MEDICAL INC Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
Apr, 2029

(5 years from now)

Triferic Avnu is owned by Rockwell Medical Inc.

Triferic Avnu contains Ferric Pyrophosphate Citrate.

Triferic Avnu has a total of 1 drug patent out of which 0 drug patents have expired.

Triferic Avnu was authorised for market use on 27 March, 2020.

Triferic Avnu is available in solution;intravenous dosage forms.

Triferic Avnu can be used as method of iron administration to treat patients in need of iron replacement therapy.

The generics of Triferic Avnu are possible to be released after 17 April, 2029.

Drugs and Companies using FERRIC PYROPHOSPHATE CITRATE ingredient

Market Authorisation Date: 27 March, 2020

Treatment: Method of iron administration to treat patients in need of iron replacement therapy


More Information on Dosage

TRIFERIC AVNU family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic